Lumora’s approach to business is to license intellectual property exclusively to industry leaders in a specific field and then work with them to develop world class products. For example, Lumora's BART technology has been exclusively licensed to 3M for the in vitro molecular testing in food, beverages and feed for animals, in its latest innovation, the 3M™ Molecular Detection System.
We select applications where the features of BART and our other unique technologies provide significant advantages over established molecular diagnostic approaches; typically those benefits include ease-of-use, greater robustness and lower cost to manufacture. Lumora can design, develop and optimise tests for partners, supplying them with unique lyophilised tests and an instrument platform on which the partner can perform their own validation studies.
A number of clinical (e.g. chlamydia, C diff, HIV viral load) and industrial (e.g. GMO, authenticity) assays have been built and tested, and we are in active discussion with potential licensees.